Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (5): 1305-1312.doi: 10.13481/j.1671-587X.20240514
• Research in basic medicine • Previous Articles Next Articles
Chunjing LIU,Yujie YANG,Wei ZHAO,Lijing LIU,Na WANG(
)
Received:2023-11-13
Online:2024-09-28
Published:2024-10-28
Contact:
Na WANG
E-mail:liuchunjing126@126.com
CLC Number:
Chunjing LIU,Yujie YANG,Wei ZHAO,Lijing LIU,Na WANG. Effect of silencing CDC20 on proliferation and cell cycle of endometrial cancer cells by inhibiting Wnt/β-catenin signaling pathway[J].Journal of Jilin University(Medicine Edition), 2024, 50(5): 1305-1312.
| 1 | CROSBIE E J, KITSON S J, MCALPINE J N, et al. Endometrial cancer[J]. Lancet, 2022, 399(10333):1412-1428. |
| 2 | EID M, GONTHIER C, BUCAU M, et al. Conservative treatments for endometrial cancer[J]. Rev Prat, 2022, 72(7): 747-749. |
| 3 | GARG V, JAYARAJ A, KUMAR L. Novel approaches for treatment of endometrial carcinoma[J]. Curr Probl Cancer, 2022, 46(5):100895. |
| 4 | MARKOWSKA A, CHUDECKA-GŁAZ A, PITYŃSKI K, et al. Endometrial cancer management in young women[J]. Cancers (Basel), 2022, 14(8): 1922. |
| 5 | HE W N, MENG J. CDC20: a novel therapeutic target in cancer[J]. Am J Transl Res, 2023, 15(2): 678-693. |
| 6 | JEONG S M, BUI Q T, KWAK M, et al. Targeting Cdc20 for cancer therapy[J]. Biochim Biophys Acta Rev Cancer, 2022, 1877(6):188824. |
| 7 | CHU Z W, ZHANG X Y, LI Q Y, et al. CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β-catenin signaling pathway[J]. Int J Oncol, 2019, 54(5):1534-1544. |
| 8 | HADJIHANNAS M V, BERNKOPF D B, BRÜCKNER M, et al. Cell cycle control of Wnt/β-catenin signalling by conductin/axin2 through CDC20[J]. EMBO Rep, 2012, 13(4):347-354. |
| 9 | ZHANG Q L, WANG Y M, XUE F X. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG may serve as diagnostic and prognostic biomarkers in endometrial carcinoma[J]. Genet Res (Camb), 2022, 2022: 3217248. |
| 10 | MORONEY M R, WOODRUFF E, QAMAR L, et al. Inhibiting wnt/beta-catenin in CTNNB1-mutated endometrial cancer[J]. Mol Carcinog, 2021, 60(8):511-523. |
| 11 | ANDO K, NAKAGAWARA A. Acceleration or brakes: which is rational for cell cycle-targeting neuroblastoma therapy?[J]. Biomolecules, 2021, 11(5): 750. |
| 12 | NI K, HONG L. Current progress and perspectives of CDC20 in female reproductive cancers[J]. Curr Mol Med, 2023, 23(3):193-188. |
| 13 | BHUNIYA R, YUAN X R, BAI L C, et al. Design, synthesis, and biological evaluation of apcin-based CDC20 inhibitors[J]. ACS Med Chem Lett, 2022, 13(2):188-195. |
| 14 | FATIMA I, BARMAN S, RAI R, et al. Targeting wnt signaling in endometrial cancer[J]. Cancers, 2021, 13(10): 2351. |
| 15 | XIONG J, XING S G, DONG Z, et al. STK31 regulates the proliferation and cell cycle of lung cancer cells via the Wnt/β-catenin pathway and feedback regulation by c-myc[J]. Oncol Rep, 2020, 43(2):395-404. |
| 16 | ZHAO Z Q, WU X J, CHENG Y H, et al. TROAP regulates cell cycle and promotes tumor progression through Wnt/β-catenin signaling pathway in glioma cells[J]. CNS Neurosci Ther, 2021, 27(9): 1064-1076. |
| 17 | YE R Y, KUANG X Y, SHAO N, et al. Downregulation of NPTX1 induces cell cycle progression through Wnt/β-catenin signaling in breast cancer[J]. J Biol Regul Homeost Agents, 2021, 35(3):1177-1183. |
| 18 | KAPOOR S, PADWAD Y. Phloretin induces G2/M arrest and apoptosis by suppressing the β-catenin signaling pathway in colorectal carcinoma cells[J]. Apoptosis, 2023, 28(5/6):810-829. |
| 19 | 李大众, 黄敏敏, 刘慧玲. 富含半胱氨酸蛋白61对子宫内膜癌细胞增殖及细胞周期的影响及其机制研究[J]. 中国现代医学杂志, 2022, 32(21):13-17. |
| 20 | GARCÍA-GUTIÉRREZ L, DELGADO M D, LEÓN J. MYC oncogene contributions to release of cell cycle brakes[J]. Genes, 2019, 10(3):244. |
| 21 | 黄莹莹, 陈 誉, 费召东, 等. 细胞周期蛋白D1的研究现状及展望[J]. 中华转移性肿瘤杂志, 2021, 4(1):70-75. |
| 22 | 陆 芳, 周健红, 陈宇航, 等. 绝经后期子宫内膜增厚与子宫内膜癌的风险因素分析及列线图预测模型构建[J]. 同济大学学报(医学版), 2023, 44(1): 24-31. |
| 23 | LI K, MAO Y H, LU L, et al. Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel[J]. Int J Oncol, 2016, 49(4):1679-1685. |
| [1] | Hong LI,Panpan YU,Zouyu ZHAO,Chongfeng SUN,Hui QIAO,Ping YANG. Expression of GSTO1 in ovarian cancer tissue and effect of N-glycosylation site mutations on biological behaviors of epithelial ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 469-482. |
| [2] | Teng LIU,Ning ZHANG,Mingyuan HE,Guanghui CHENG. Research progress in treatment principles for endometrial cancer and its postoperative and postoperative recurrent radiotherapy [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1747-1754. |
| [3] | Ming CHEN,Qinghua LUO,Hongguang JIN,Liang HAN. Atypical lipomatous tumor of left lower limb: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1384-1389. |
| [4] | Rongmian YAN,Xinting SUN,Xin GUAN,Yu CHENG,Liying HAN. Effects of KLK5 overexpression on growth of subcutaneous xenograft tumor and cisplatin sensitivity in nude mice [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1194-1203. |
| [5] | Xialing HUANG,Dandan ZHANG,Xuemei ZHANG. Analysis on relationship between methylation of MSX1 gene and clinical pathological features and prognosis of patients with cervical cancer [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 749-756. |
| [6] | Yanyan LU,Xiangbo XU,Yamei WU,Yuqi LIU,Han WANG,Lijuan YANG,Zhenjiang WANG,Zishen XIAO,Yanbo LIU. Eosinophil infiltration in cervical lesion and cervical cancer tissues and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1691-1702. |
| [7] | Changji ZHU,Xingzhe LIU,Yanhua XUAN. Effect of hypoxia on expressions of Gli1 and Sox2 in cervical cancer SiHa cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 442-450. |
| [8] | Rongxia JIA,Xu ZHOU,Zhikun SHI,Meijing BAO,Guanqun WANG,Yuqing CHU,Yang LIN. Analysis on risk factors for disease progression of patients with cervical intraepithelial neoplasia Ⅰ [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1528-1534. |
| [9] | Guowu WANG,Yuan YAO,Yu ZHANG,Na XU,Fang LIU. Inhibitory effect of miR-152 on proliferation and invasion of endometrial carcinoma cells by reducing low-density lipoprotein receptor expression [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 591-599. |
| [10] | Xingyu ZHAO,Xin YANG,Zhihua ZHU,Han HE,Zitong SONG,Wei ZHANG. Inhibitory effect of juglone on proliferation of cervical cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 348-355. |
| [11] | Aiping WEN,Le LUO,Zhiwei MENG,Jingji JIN,Honggui ZHOU,Jihong ZHU. Expression of Tip60 protein in endometrial adenocarcinoma tissue and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1244-1249. |
| [12] | Dongli ZHANG,Ruifang FU,Guixia SUN. Effect of oxymatrine on proliferation and apoptosis of cervical cancer SiHa cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 951-957. |
| [13] | Lijing QIN,Bing HAN,Zhongqi LI,Qi SUO,Zhen JIA,Hongli CUI,Weiqiang XU,Fang FANG,Zhicheng WANG. Effects of targeting-silenced ATRX on cell cycle arrest and apoptosis induced by radiation in cervical cancer HeLa cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 904-910. |
| [14] | Dan SU, Yi LIU, Manman CUI, Nian YANG, Yu HUANG, Wenjing HE. Evaluation of clinical effect of screening chemotherapy regimens in treatment of ovarian cancer based on miniPDX animal models [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 731-739. |
| [15] | Lan ZHENG,Songzhe PIAO,Ran XU,Xinyue WANG,Yixuan WANG,Zhenhua LIN,Yang YANG. Bioinformatics analysis based on effect of expression levels of m6A regulators on immune infiltration and prognosis of uterine corpus endometrial carcinoma [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 438-452. |